A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

Clinical trial NCT06712628 · RECRUITING

Trial details

NCT number: NCT06712628
Sponsor: AbbVie
Status: RECRUITING
Study type: OBSERVATIONAL

Moderate to Severe Rheumatoid Arthritis

Start date: 2024-11-07
Primary completion: 2028-12-01
Enrollment: 678

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.